Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C662
http://purl.obolibrary.org/obo/NCIT_C662
|
|---|---|
| Preferred Name | Mitolactol |
| Definitions |
A synthetic derivative of hexitol with antineoplastic and radiosensitizing properties. Mitolactol alkylates DNA via actual or derived epoxide groups, resulting in inhibition of DNA and RNA synthesis. (NCI04)
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A synthetic derivative of hexitol with antineoplastic and radiosensitizing properties. Mitolactol alkylates DNA via actual or derived epoxide groups, resulting in inhibition of DNA and RNA synthesis. (NCI04) |
|---|---|
| prefLabel | Mitolactol
|
| label | Mitolactol
|
| PDQ_Closed_Trial_Search_ID | 39216
|
| code | C662
|
| prefixIRI | NCIT:C662
|
| in_subset | |
| Preferred_Name | Mitolactol
|
| FDA_UNII_Code | LJ2P1SIK8Y
|
| Contributing_Source | FDA
|
| Chemical_Formula | C6H12Br2O4
|
| Maps_To | Mitolactol
|
| CAS_Registry | 10318-26-0
|
| NSC Number | 104800
|
| NCI_Drug_Dictionary_ID | 39216
|
| Legacy Concept Name | Mitolactol
|
| type | |
| ALT_DEFINITION | An anticancer drug that belongs to the family of drugs called alkylating agents.
|
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 39216
|
| Semantic_Type |
Organic Chemical
Pharmacologic Substance
|
| UMLS_CUI | C0026252
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |